In this video, Sigurdur Kristinsson, MD, PhD, University of Iceland, Reykjavík, Iceland, discusses the development of a multivariate model to predict which patients with monoclonal gammopathy of undetermined significance (MGUS) have a higher risk of progression to smoldering multiple myeloma (SMM), using data from the ongoing iStopMM study (NCT03327597). This interview took place at the 64th ASH Annual Meeting and Exposition congress held in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть